Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul T Bremer

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|November 9, 2012
Investigating the effects of a hydrolytically stable hapten and a Th1 adjuvant on heroin vaccine performancePaul T Bremer, Kim D Janda
Pharmacological Reviews|June 22, 2017
Conjugate Vaccine Immunotherapy for Substance Use DisorderPaul T Bremer, Kim D Janda
Chemical Communications (Cambridge, England)|October 11, 2016
Picolinic acids as β-exosite inhibitors of botulinum neurotoxin A light chainPaul T Bremer, Song Xue, Kim D Janda
Bioorganic & Medicinal Chemistry|July 3, 2014
Benzoquinones as inhibitors of botulinum neurotoxin serotype APaul T Bremer, Mark S Hixon, Kim D Janda
Molecular Pharmaceutics|February 13, 2014
Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacyPaul T Bremer, Joel E Schlosburg, Jenny M Lively, et al.
Nature Communications|December 5, 2023
Investigation of monoclonal antibody CSX-1004 for fentanyl overdosePaul T Bremer, Emily L Burke, Andrew C Barrett, et al.
Journal of Medicinal Chemistry|April 8, 2016
Methamphetamine Vaccines: Improvement through Hapten DesignKaren C Collins, Joel E Schlosburg, Paul T Bremer, et al.
Journal of Medicinal Chemistry|December 15, 2016
Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo AssaysPaul T Bremer, Michael Adler, Cecilia H Phung, et al.
ACS Chemical Biology|February 3, 2021
A Highly Efficacious Carfentanil Vaccine That Blunts Opioid-Induced Antinociception and Respiratory DepressionLisa M Eubanks, Steven Blake, Yoshihiro Natori, et al.
Angewandte Chemie (International Ed. in English)|February 17, 2016
Combatting Synthetic Designer Opioids: A Conjugate Vaccine Ablates Lethal Doses of Fentanyl Class DrugsPaul T Bremer, Atsushi Kimishima, Joel E Schlosburg, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|November 9, 2012
Investigating the effects of a hydrolytically stable hapten and a Th1 adjuvant on heroin vaccine performancePaul T Bremer, Kim D Janda
Pharmacological Reviews|June 22, 2017
Conjugate Vaccine Immunotherapy for Substance Use DisorderPaul T Bremer, Kim D Janda
Chemical Communications (Cambridge, England)|October 11, 2016
Picolinic acids as β-exosite inhibitors of botulinum neurotoxin A light chainPaul T Bremer, Song Xue, Kim D Janda
Bioorganic & Medicinal Chemistry|July 3, 2014
Benzoquinones as inhibitors of botulinum neurotoxin serotype APaul T Bremer, Mark S Hixon, Kim D Janda
Molecular Pharmaceutics|February 13, 2014
Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacyPaul T Bremer, Joel E Schlosburg, Jenny M Lively, et al.
Nature Communications|December 5, 2023
Investigation of monoclonal antibody CSX-1004 for fentanyl overdosePaul T Bremer, Emily L Burke, Andrew C Barrett, et al.
Journal of Medicinal Chemistry|April 8, 2016
Methamphetamine Vaccines: Improvement through Hapten DesignKaren C Collins, Joel E Schlosburg, Paul T Bremer, et al.
Journal of Medicinal Chemistry|December 15, 2016
Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo AssaysPaul T Bremer, Michael Adler, Cecilia H Phung, et al.
ACS Chemical Biology|February 3, 2021
A Highly Efficacious Carfentanil Vaccine That Blunts Opioid-Induced Antinociception and Respiratory DepressionLisa M Eubanks, Steven Blake, Yoshihiro Natori, et al.
Angewandte Chemie (International Ed. in English)|February 17, 2016
Combatting Synthetic Designer Opioids: A Conjugate Vaccine Ablates Lethal Doses of Fentanyl Class DrugsPaul T Bremer, Atsushi Kimishima, Joel E Schlosburg, et al.
Pageof 3